EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Endothelin receptor antagonists in diabetic and non-diabetic chronic kidney disease

Vanja Ivković, Annette Bruchfeld iD

Clinical Kidney Journal · 01.04.2024 · 17 (4)

DOI: 10.1093/ckj/sfae072 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Kidney Journal, online erschienen am 19.03.2024. Verfasst von Vanja Ivković und 1 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital Center Zagreb, Department of Nephrology, Hypertension, Dialysis and Transplantation, Zagreb, Croatia. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease (CKD) is one of the major causes of morbidity and mortality, affecting >800 million persons globally. While we still lack efficient, targeted therapies addressing the major underlying pathophysiologic processes in CKD, findings of several recent trials have brought about a shifting landscape of promising therapies. The endothelin system has been implicated in the pathophysiology of CKD and endothelin receptor antagonists are one class of drugs for which we have increasing evidence of efficacy in these patients. In this review we summarize the most recent findings on the safety and efficacy of endothelin receptor antagonists in diabetic and non-diabetic CKD, future directions of research and upcoming treatments.

Schlagwörter

Stichwörter der Autor:innen

chronic kidney diseasedrugsendothelinendothelin receptor antagonistsreview

Autor:innen und Institutionen

  • University Hospital Center Zagreb, Department of Nephrology, Hypertension, Dialysis and Transplantation, Zagreb, Croatia.
  • University of Rijeka, Faculty of Health Studies, Rijeka, Croatia.
  • Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
  • Department of Renal Medicine, Karolinska University Hospital and CLINTEC Karolinska Institutet, Stockholm, Sweden.

ORCID-Profile: Annette Bruchfeld

Zitieren

APA

Ivković, V., & Bruchfeld, A. (2024). Endothelin receptor antagonists in diabetic and non-diabetic chronic kidney disease. Clinical Kidney Journal, 17(4). https://doi.org/10.1093/ckj/sfae072

Vancouver

Ivković V, Bruchfeld A. Endothelin receptor antagonists in diabetic and non-diabetic chronic kidney disease. Clinical Kidney Journal. 2024;17(4). doi:10.1093/ckj/sfae072

BibTeX
@article{Ivkovi2024,
  author = {Ivković, Vanja and Bruchfeld, Annette},
  title = {Endothelin receptor antagonists in diabetic and non-diabetic chronic kidney disease},
  journal = {Clinical Kidney Journal},
  year = {2024},
  volume = {17},
  number = {4},
  doi = {10.1093/ckj/sfae072}
}
Kostenlos starten →